HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chris Orvig Selected Research

Lanthanoid Series Elements (Lanthanides)

6/2021Evaluation of La(XT), a novel lanthanide compound, in an OVX rat model of osteoporosis.
1/2014H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
5/2013In vitro studies of lanthanide complexes for the treatment of osteoporosis.
11/2007Lanthanide containing compounds for therapeutic care in bone resorption disorders.
6/2006Editorial: lanthanide compounds for therapeutic and diagnostic applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chris Orvig Research Topics

Disease

17Neoplasms (Cancer)
01/2022 - 12/2004
7Alzheimer Disease (Alzheimer's Disease)
03/2014 - 01/2007
3Osteoporosis
06/2021 - 05/2013
3Type 2 Diabetes Mellitus (MODY)
04/2009 - 05/2004
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2021
2Leukemia
01/2021 - 10/2020
2Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 08/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
02/2014 - 02/2013
2Diabetes Mellitus
04/2009 - 04/2002
2Lymphoma (Lymphomas)
11/2005 - 12/2004
1Infections
11/2021
1Inflammation (Inflammations)
11/2021
1Hypoxia (Hypoxemia)
05/2015
1Cardiotoxicity
02/2015
1Malaria
02/2013
1Bone Resorption
11/2007
1Osteosarcoma (Osteogenic Sarcoma)
06/2006
1Pain (Aches)
06/2006
1Acquired Immunodeficiency Syndrome (AIDS)
05/2003
1Insulin Resistance
02/2002

Drug/Important Bio-Agent (IBA)

8MetalsIBA
11/2021 - 05/2003
5Lanthanoid Series Elements (Lanthanides)IBA
06/2021 - 06/2006
5LigandsIBA
02/2019 - 11/2005
4Chelating AgentsIBA
01/2021 - 02/2013
4Pharmaceutical PreparationsIBA
01/2021 - 12/2016
4Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2013
4IonsIBA
03/2014 - 06/2007
3Peptides (Polypeptides)IBA
01/2022 - 06/2007
3Immunoconjugates (Immunoconjugate)IBA
01/2017 - 08/2013
3Vanadates (Orthovanadate)IBA
04/2009 - 12/2004
3Insulin (Novolin)FDA Link
04/2009 - 02/2002
2LanthanumIBA
06/2021 - 12/2016
2Trastuzumab (Herceptin)FDA Link
01/2021 - 01/2016
2CopperIBA
10/2020 - 11/2019
2ProdrugsIBA
04/2009 - 12/2008
2ethyl maltolIBA
04/2009 - 04/2009
2VanadiumIBA
04/2009 - 05/2004
1Type 1 Melanocortin ReceptorIBA
01/2022
1Fetal Proteins (Fetoprotein)IBA
01/2022
1Radioisotopes (Radionuclides)IBA
01/2022
1Oxyquinoline (8 Hydroxyquinoline)FDA Link
11/2021
1IsotopesIBA
11/2021
1Monoclonal AntibodiesIBA
01/2021
1Glycyrrhetinic Acid (Po 12)IBA
01/2021
1Antineoplastic Agents (Antineoplastics)IBA
01/2021
1AcidsIBA
01/2021
1LipidsIBA
01/2021
1Liposomes (Liposome)IBA
01/2021
1Asialoglycoprotein ReceptorIBA
01/2021
1MicellesIBA
01/2021
1Carbolines (Beta-Carbolines)IBA
11/2019
1AZD5991IBA
11/2019
1isoquinolineIBA
02/2019
1GoldIBA
02/2019
1Cisplatin (Platino)FDA LinkGeneric
02/2019
1RadiopharmaceuticalsIBA
01/2019
1Diphosphonates (Bisphosphonates)IBA
12/2016
1Coordination ComplexesIBA
12/2016
1Alendronate (Alendronate Sodium)FDA LinkGeneric
12/2016
1Organophosphonates (Phosphonates)IBA
12/2016
1Durapatite (Hydroxylapatite)IBA
12/2016
1Pentetic Acid (DTPA)FDA LinkGeneric
01/2016
1GalliumIBA
01/2016
1N,N'- ((6- carboxylato)pyridin- 2- yl)methyl)- 1,2- diaminoethaneIBA
05/2015
1NitroimidazolesIBA
05/2015
1IronIBA
02/2015
1QuinolonesIBA
02/2015
1AnthracyclinesIBA
02/2015
1PlatinumIBA
09/2014
1Amyloidogenic ProteinsIBA
02/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2014
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
08/2013
1Cholinesterase Inhibitors (Anticholinesterases)IBA
04/2013
1DeferiproneIBA
04/2013
1Chloroquine (Aralen)FDA LinkGeneric
02/2013
1ferroquineIBA
02/2013
1maltolIBA
04/2009
1bis(ethylmaltolato)oxovanadium(IV)IBA
04/2009
1bis(maltolato)oxovanadium(IV)IBA
04/2009
1AntioxidantsIBA
12/2008
1Amyloid beta-PeptidesIBA
06/2007
1Contrast MediaIBA
06/2006
1diphenyl (biphenyl)IBA
11/2005
1BromidesIBA
11/2005
1CurcuminIBA
12/2004
1Biological ProductsIBA
12/2004
1Hypoglycemic Agents (Hypoglycemics)IBA
12/2004
1Streptozocin (Streptozotocin)FDA Link
12/2004
1Vanadium CompoundsIBA
04/2002
1Therapeutic UsesIBA
04/2002

Therapy/Procedure

5Therapeutics
01/2022 - 04/2009
1Aftercare (After-Treatment)
01/2022
1Radioimmunotherapy
01/2016